The cancer burden continues to grow globally, and drug resistance remains a substantial
challenge in cancer therapy. It is well established that cancerous cells with clonal dysplasia …

Glycosylation, the major post‐translational modification of proteins, significantly increases
the diversity of proteoforms. Glycans are involved in a variety of pivotal structural and …

Background Extracellular matrix (ECM) acts as a physical barrier to tumors, resulting in the
lysis or delay of drug delivery. Integrins (ITGs) are essential for tumor cell-ECM interactions …

2-phenylchromen-4-one, commonly known as flavone, plays multifaceted roles in biological
response that can be abundantly present in natural sources. The methoxy group in naturally …

The identification of new cancer-associated genes/proteins, the characterization of their
expression variation, the interactomics-based assessment of differentially expressed …

Hepatocellular carcinoma (HCC) is a primary malignant tumour, ranking second in global
mortality rates and posing significant health threats. Epigenetic alterations, particularly DNA …

Metastasis, the leading cause of death in cancer patients, arises when cancer cells
disseminate from a primary solid tumour to distant organs. Growth and invasion of the solid …

Área de Estudio: Nanomedicina Propósito y Método del Estudio: El receptor 2 del factor de
crecimiento epidérmico humano (HER2) es una proteína transmembranal involucrada en el …

Extracellular vesicles (EVs) are cell-derived vesicles secreted by all cell types into the
extracellular spaces. EVs comprise a heterogenous population of vesicles that carry …

2-phenylchromen-4-one, commonly known as flavone, plays multifaceted roles in biological
response, largely due to its abundance in natural sources. The methoxy group in naturally …